Tracking inflammatory bowel disease progress and complications
Part of Digestive system clinical trials.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are able to give your consent and are covered by a health insurance plan
- You have a diagnosis of Crohn's disease or ulcerative colitis confirmed at Saint-Antoine Hospital
- You have not had colon preparation (cleansing for a colonoscopy) in the 6 weeks before providing a stool sample
- You can speak and understand French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This trial is a monitoring study for people with inflammatory bowel diseases (IBD), such as Crohn's disease or ulcerative colitis. It aims to follow patients who have been seen at a specialized IBD center to gather information and improve care.
This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
Hear when a new Crohn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.